Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Broadfoot Jill Marie
Chief Financial Officer at aTYR PHARMA. Filing since 14 Sep 2018.
CIK 0001305178
Company
Date
Role
Action
Shares
Amount
Of holding
ATYR
aTYR PHARMA INC
4 Feb 2026
Chief Financial Officer
Sold at will
1,558
$1.52K
4.0%
ATYR
aTYR PHARMA INC
4 Feb 2025
Chief Financial Officer
Sold at will
1,254
$4.74K
3.8%
ATYR
aTYR PHARMA INC
31 May 2024
Chief Financial Officer
Bought
5,000
$8.95K
21.8%
ATYR
aTYR PHARMA INC
6 Feb 2024
Chief Financial Officer
Sold at will
1,590
$2.69K
7.1%
ATYR
aTYR PHARMA INC
6 Feb 2023
Chief Financial Officer
Sold, plan not stated
1,566
$3.70K
9.2%
ATYR
aTYR PHARMA INC
13 Jan 2022
Chief Financial Officer
Bought
1,923
$12.98K
18.9%
ATYR
aTYR PHARMA INC
9 Feb 2021
Chief Financial Officer
Sold, plan not stated
390
$2.99K
3.8%
ATYR
aTYR PHARMA INC
19 Jun 2020
Chief Financial Officer
Bought
1,850
$7.81K
25.3%
ATYR
aTYR PHARMA INC
7 Feb 2020
Chief Financial Officer
Sold, plan not stated
375
$1.51K
5.0%
ATYR
aTYR PHARMA INC
20 Sep 2018
Chief Financial Officer
Bought
38,000
$31.74K
73.1%
ATYR
aTYR PHARMA INC
19 Sep 2018
Chief Financial Officer
Bought
26,000
$21.12K
100%
ATYR
aTYR PHARMA INC
14 Sep 2018
Chief Financial Officer
Bought
26,000
$19.06K
opened
12 decisions on file.
